Martin Kryspin Sørensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin Kryspin Sørensen has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Lars Simon Rasmussen
Danish Ministry of Defence, Personnel Agency Copenhagen Denmark
4 shared publications C. Bretlau
Copenhagen , Denmark
2 shared publicationsA. M. SØRensen
Copenhagen , Denmark
1 shared publicationA. M. Sørensen
Department of Anaesthesia, Centre of Head and Orthopaedics , Copenhagen University Hospital , Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen , Denmark
1 shared publication- Aleena Azam
Department of Neurosurgery, Neuroscience Center, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
1 shared publication Alexandra Vassilieva
Neuroanaesthesiology
1 shared publication
Latest Publications
- 7 July 2025
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (1) , 90-92
Factors Associated With Prolonged Hospital Stay After Craniotomy for Tumor
- 7 July 2025
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (1) , 90-92
Factors Associated With Prolonged Hospital Stay After Craniotomy for Tumor
- Open Access
- 3 June 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97 (6) , 1418-1427
Novel Urokinase-Type Plasminogen Activator Receptor-Targeting Optical Imaging Agent ICG-Glu-Glu-AE105 for Visualization of Malignant Glioma During Surgery: First-in-Human Study in 35 Patients with Brain Cancer
BACKGROUND AND OBJECTIVES: Glioblastoma is an aggressive form of brain cancer for which surgery is the keystone in treatment before oncological treatment. Improving surgical resection without jeopardizing the outcome is eminent, and a fluorescent drug to aid surgical outcome is warranted. To evaluate the safety and the efficacy of a novel urokinase-type Plasminogen Activator Receptor-targeting near-infrared optical imaging agent, ICG-Glu-Glu-AE105 (FG001), in patients with malignant glioma (glioblastoma). METHODS: First-in-human phase I dose escalation and time elaboration study in 35 patients undergoing surgery for glioblastoma. The tumor-to-background ratio (TBR) was measured on near-infrared images as an objective measure of image contrast. Biopsies were taken during surgery from areas with and without fluorescence (FG001) and compared with pathology as reference. Efficacy was evaluated as sensitivity and specificity of FG001 to detect tumor tissue. The study was conducted with close safety monitoring. RESULTS: Administration of FG001 at a dose of 36 mg, 12 to 17 hours before surgery, resulted in optimal image contrast between tumor and normal brain tissue, with a mean TBR of 3.6. A high sensitivity (79%) and specificity (100%) for the detection of tumor tissue was found. Safety monitoring during the study identified only a few related adverse events, all of which were of mild grade. CONCLUSION: FG001 was found to be safe and well tolerated in the patients included in the study. The optimal dose of FG001 was selected on the basis of videos taken during the surgery and the measured TBR values. A dose of 36 mg administered 16 hours (mean) before the surgery showed the best contrast (TBR values) and optimal visualization of the tumor delineation. Histology demonstrated good sensitivity of FG001.
- 3 June 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 97 (6) , 1418-1427
Open AccessNovel Urokinase-Type Plasminogen Activator Receptor-Targeting Optical Imaging Agent ICG-Glu-Glu-AE105 for Visualization of Malignant Glioma During Surgery: First-in-Human Study in 35 Patients with Brain Cancer
BACKGROUND AND OBJECTIVES: Glioblastoma is an aggressive form of brain cancer for which surgery is the keystone in treatment before oncological treatment. Improving surgical resection without jeopardizing the outcome is eminent, and a fluorescent drug to aid surgical outcome is warranted. To evaluate the safety and the efficacy of a novel urokinase-type Plasminogen Activator Receptor-targeting near-infrared optical imaging agent, ICG-Glu-Glu-AE105 (FG001), in patients with malignant glioma (glioblastoma). METHODS: First-in-human phase I dose escalation and time elaboration study in 35 patients undergoing surgery for glioblastoma. The tumor-to-background ratio (TBR) was measured on near-infrared images as an objective measure of image contrast. Biopsies were taken during surgery from areas with and without fluorescence (FG001) and compared with pathology as reference. Efficacy was evaluated as sensitivity and specificity of FG001 to detect tumor tissue. The study was conducted with close safety monitoring. RESULTS: Administration of FG001 at a dose of 36 mg, 12 to 17 hours before surgery, resulted in optimal image contrast between tumor and normal brain tissue, with a mean TBR of 3.6. A high sensitivity (79%) and specificity (100%) for the detection of tumor tissue was found. Safety monitoring during the study identified only a few related adverse events, all of which were of mild grade. CONCLUSION: FG001 was found to be safe and well tolerated in the patients included in the study. The optimal dose of FG001 was selected on the basis of videos taken during the surgery and the measured TBR values. A dose of 36 mg administered 16 hours (mean) before the surgery showed the best contrast (TBR values) and optimal visualization of the tumor delineation. Histology demonstrated good sensitivity of FG001.
- 6 April 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (4) , e247364
Subarachnoid haemorrhage in a patient with undiagnosed aortic coarctation
A man in his mid-30s was admitted with a thunderclap headache. He was conscious and hypertensive. A decade earlier, severe hypertension had been diagnosed and extensively investigated without revealing an underlying cause. Brain imaging showed subarachnoid haemorrhage caused by a ruptured pericallosal aneurysm. Endovascular occlusion was attempted, but as the sheath could not pass the aortic arch, it was converted to surgical aneurismal clipping. Intraoperative blood pressure measurement revealed a peak-to-peak gradient of 100 mm Hg across the aortic arch and an ankle/brachial index of 0.46 (normal range 0.9–1.2). Aortic coarctation was suspected, and angiographic imaging and echocardiography confirmed the diagnosis. Subacute direct stenting was performed, which normalised the peak-to-peak gradient and ankle/brachial index. To minimise the risk of severe complications, early diagnosis of aortic coarctation is important and can be facilitated by ankle/brachial index and echocardiography in the suprasternal view.
- 6 April 2022
- Published by BMJ in BMJ Case Reports
- Vol. 15 (4) , e247364
Subarachnoid haemorrhage in a patient with undiagnosed aortic coarctation
A man in his mid-30s was admitted with a thunderclap headache. He was conscious and hypertensive. A decade earlier, severe hypertension had been diagnosed and extensively investigated without revealing an underlying cause. Brain imaging showed subarachnoid haemorrhage caused by a ruptured pericallosal aneurysm. Endovascular occlusion was attempted, but as the sheath could not pass the aortic arch, it was converted to surgical aneurismal clipping. Intraoperative blood pressure measurement revealed a peak-to-peak gradient of 100 mm Hg across the aortic arch and an ankle/brachial index of 0.46 (normal range 0.9–1.2). Aortic coarctation was suspected, and angiographic imaging and echocardiography confirmed the diagnosis. Subacute direct stenting was performed, which normalised the peak-to-peak gradient and ankle/brachial index. To minimise the risk of severe complications, early diagnosis of aortic coarctation is important and can be facilitated by ankle/brachial index and echocardiography in the suprasternal view.
- 22 April 2021
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 89 (1) , E105-E106
Letter: Enhanced Recovery After Neurosurgery for Brain Tumors – A Critical Reappraisal
- 22 April 2021
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 89 (1) , E105-E106
Letter: Enhanced Recovery After Neurosurgery for Brain Tumors – A Critical Reappraisal
- 1 September 2016
- Published by Elsevier in Journal of Voice
- Vol. 30 (5) , 626-630
Normative Values and Interrelationship of MDVP Voice Analysis Parameters Before and After Endotracheal Intubation
- 1 September 2016
- Published by Elsevier in Journal of Voice
- Vol. 30 (5) , 626-630
Normative Values and Interrelationship of MDVP Voice Analysis Parameters Before and After Endotracheal Intubation
- 18 March 2013
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 57 (6) , 814-815
PhD thesis: aspects of rapid sequence induction
- 18 March 2013
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 57 (6) , 814-815
PhD thesis: aspects of rapid sequence induction
- 5 February 2013
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 57 (6) , 737-744
Laryngeal morbidity after tracheal intubation: the Endoflex® tube compared to conventional endotracheal intubation with stylet
Background: Tracheal intubation may cause vocal fold damage. The trial was designed to assess laryngeal morbidity comparing the Endoflex® tube with a conventional endotracheal tube with stylet. We hypothesised that laryngeal morbidity within the first 24 h after extubation would be lower with the Endoflex tube than with the conventional endotracheal tube with stylet because of less rigidity.Methods: This randomised trial included 130 elective surgical patients scheduled for general anaesthesia with endotracheal intubation. Pre‐ and post‐operative assessment of hoarseness, vocal fold pathology, and voice analysis using the Multidimensional Voice Program was performed. Induction of anaesthesia was standardised. After complete neuromuscular paralysis, intubation was done with an Endoflex tube or a conventional endotracheal tube with stylet.Results: Post‐operative hoarseness was found in 45% with the Endoflex tube and 55% with the endotracheal tube with stylet at 24 h after extubation (P = 0.44). Post‐operative vocal fold injury was present in 23% in the Endoflex tube group and in 36% in the endotracheal tube with stylet group (P = 0.13). The increase in shimmer, the voice analysis variable reflecting vocal fold oedema, was 0.5% in the Endoflex tube group and 2.5% in the endotracheal tube with stylet group (P = 0.02).Conclusion: No significant difference was found in the incidence of hoarseness or vocal fold injury using the Endoflex tube. However, the statistically significant lower increase in the shimmer values in that group implies that the Endoflex may be associated with less laryngeal morbidity.
- 5 February 2013
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 57 (6) , 737-744
Laryngeal morbidity after tracheal intubation: the Endoflex® tube compared to conventional endotracheal intubation with stylet
Background: Tracheal intubation may cause vocal fold damage. The trial was designed to assess laryngeal morbidity comparing the Endoflex® tube with a conventional endotracheal tube with stylet. We hypothesised that laryngeal morbidity within the first 24 h after extubation would be lower with the Endoflex tube than with the conventional endotracheal tube with stylet because of less rigidity.Methods: This randomised trial included 130 elective surgical patients scheduled for general anaesthesia with endotracheal intubation. Pre‐ and post‐operative assessment of hoarseness, vocal fold pathology, and voice analysis using the Multidimensional Voice Program was performed. Induction of anaesthesia was standardised. After complete neuromuscular paralysis, intubation was done with an Endoflex tube or a conventional endotracheal tube with stylet.Results: Post‐operative hoarseness was found in 45% with the Endoflex tube and 55% with the endotracheal tube with stylet at 24 h after extubation (P = 0.44). Post‐operative vocal fold injury was present in 23% in the Endoflex tube group and in 36% in the endotracheal tube with stylet group (P = 0.13). The increase in shimmer, the voice analysis variable reflecting vocal fold oedema, was 0.5% in the Endoflex tube group and 2.5% in the endotracheal tube with stylet group (P = 0.02).Conclusion: No significant difference was found in the incidence of hoarseness or vocal fold injury using the Endoflex tube. However, the statistically significant lower increase in the shimmer values in that group implies that the Endoflex may be associated with less laryngeal morbidity.
- Open Access
- 1 July 2012
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 109 (1) , 123-124
Reply from the authors
Editor—We appreciate Dr McCahon's comments and his interest in our study.1 We definitely did not study a ‘can't intubate, can't ventilate’ (CICV) situation where oxygenation through the cricothyroid membrane may be the way to proceed when desaturation has occurred.
- 1 July 2012
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 109 (1) , 123-124
Open AccessReply from the authors
Editor—We appreciate Dr McCahon's comments and his interest in our study.1 We definitely did not study a ‘can't intubate, can't ventilate’ (CICV) situation where oxygenation through the cricothyroid membrane may be the way to proceed when desaturation has occurred.
- Open Access
- 30 April 2012
- Published by Springer Nature in BMC Anesthesiology
- Vol. 12 (1) , 7
Endotracheal intubation with airtraq® versus storz® videolaryngoscope in children younger than two years - a randomized pilot-study
Background: New laryngoscopes have become available for use in small children. The aim of the study was to compare the Storz® videolaryngoscope (SVL) to the Airtraq® Optical laryngoscope (AOL) for tracheal intubation in children younger than two years of age who had a normal airway assessment. Our hypothesis was that the SVL would have a better success rate than the AOL. Methods: Ten children aged 2 years or younger scheduled for elective cleft lip/palate surgery were included. The anesthesia was standardized and a Cormack-Lehane (CL)-score was obtained using a Macintosh laryngoscope. After randomization CL-score and endotracheal tube positioning in front of the glottis was performed with one device, followed by the same procedure and intubation with the other device. The video-feed was recorded along with real-time audio. The primary endpoint was the success rate, defined as intubation in first attempt. Secondary endpoints were the time from start of laryngoscopy to CL-score, tube positioning in front of the glottis, and intubation. Results: Two intubation attempts were needed in two of five patients randomized to the SVL. The difference in time (SVL vs. AOL) to CL-score was 4.5 sec (p = 0.0449). The difference in time (SVL vs. AOL) to tube positioning was 11.6 sec (p = 0.0015). Time to intubation was 29.0 sec for SVL and 15.8 sec for AOL. Conclusion: No difference in the success rate of endotracheal intubation could be established in this ten patient sample of children younger than two years with a normal airway assessment scheduled for elective cleft lip/palate surgery. However, the Airtraq® Optical videolaryngoscope showed a number of time related advantages over the Storz® videolaryngoscope. Because of the small sample size a larger trial is needed to confirm these findings. Both devices were considered safe in all intubations. Trial registration: ClinicalTrials.gov; Identifier NCT01090726.
- 30 April 2012
- Published by Springer Nature in BMC Anesthesiology
- Vol. 12 (1) , 7
Open AccessEndotracheal intubation with airtraq® versus storz® videolaryngoscope in children younger than two years - a randomized pilot-study
Background: New laryngoscopes have become available for use in small children. The aim of the study was to compare the Storz® videolaryngoscope (SVL) to the Airtraq® Optical laryngoscope (AOL) for tracheal intubation in children younger than two years of age who had a normal airway assessment. Our hypothesis was that the SVL would have a better success rate than the AOL. Methods: Ten children aged 2 years or younger scheduled for elective cleft lip/palate surgery were included. The anesthesia was standardized and a Cormack-Lehane (CL)-score was obtained using a Macintosh laryngoscope. After randomization CL-score and endotracheal tube positioning in front of the glottis was performed with one device, followed by the same procedure and intubation with the other device. The video-feed was recorded along with real-time audio. The primary endpoint was the success rate, defined as intubation in first attempt. Secondary endpoints were the time from start of laryngoscopy to CL-score, tube positioning in front of the glottis, and intubation. Results: Two intubation attempts were needed in two of five patients randomized to the SVL. The difference in time (SVL vs. AOL) to CL-score was 4.5 sec (p = 0.0449). The difference in time (SVL vs. AOL) to tube positioning was 11.6 sec (p = 0.0015). Time to intubation was 29.0 sec for SVL and 15.8 sec for AOL. Conclusion: No difference in the success rate of endotracheal intubation could be established in this ten patient sample of children younger than two years with a normal airway assessment scheduled for elective cleft lip/palate surgery. However, the Airtraq® Optical videolaryngoscope showed a number of time related advantages over the Storz® videolaryngoscope. Because of the small sample size a larger trial is needed to confirm these findings. Both devices were considered safe in all intubations. Trial registration: ClinicalTrials.gov; Identifier NCT01090726.
- Open Access
- 6 February 2012
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 108 (4) , 682-689
Rapid sequence induction and intubation with rocuronium–sugammadex compared with succinylcholine: a randomized trial
An unanticipated difficult airway may arise during rapid sequence induction and intubation (RSII). The aim of the trial was to assess how rapidly spontaneous ventilation could be re-established after RSII. We hypothesized that the time period from tracheal intubation to spontaneous ventilation would be shorter with rocuronium–sugammadex than with succinylcholine. This randomized and patient- and observer-blinded trial was approved by the regional Ethics Committee and the Danish Medicines Agency. We included elective surgical patients undergoing general anaesthesia for RSII using alfentanil (10 µg kg−1), propofol (2 mg kg−1), and either succinylcholine (1 mg kg−1) or rocuronium (1 mg kg−1). Sugammadex (16 mg kg−1) was given in the rocuronium group after tracheal intubation. The primary endpoint was the time from correct placement of the tracheal tube to spontaneous ventilation, defined as a respiratory rate of more than 8 bpm and a tidal volume of at least 3 ml kg−1 for 30 s. We included 61 patients; of whom, 55 were evaluated for the primary endpoint. The median time from tracheal intubation to spontaneous ventilation was 406 s with succinylcholine and 216 s with rocuronium–sugammadex (P = 0.002). The median time from tracheal intubation to 90% recovery of the first twitch in train-of-four (T1 90%) was 518 s with succinylcholine and 168 s with rocuronium–sugammadex (P < 0.0001). Intubation conditions and time to tracheal intubation were not significantly different. RSII with rocuronium followed by reversal with sugammadex allowed earlier re-establishment of spontaneous ventilation than with succinylcholine.
- 6 February 2012
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 108 (4) , 682-689
Open AccessRapid sequence induction and intubation with rocuronium–sugammadex compared with succinylcholine: a randomized trial
An unanticipated difficult airway may arise during rapid sequence induction and intubation (RSII). The aim of the trial was to assess how rapidly spontaneous ventilation could be re-established after RSII. We hypothesized that the time period from tracheal intubation to spontaneous ventilation would be shorter with rocuronium–sugammadex than with succinylcholine. This randomized and patient- and observer-blinded trial was approved by the regional Ethics Committee and the Danish Medicines Agency. We included elective surgical patients undergoing general anaesthesia for RSII using alfentanil (10 µg kg−1), propofol (2 mg kg−1), and either succinylcholine (1 mg kg−1) or rocuronium (1 mg kg−1). Sugammadex (16 mg kg−1) was given in the rocuronium group after tracheal intubation. The primary endpoint was the time from correct placement of the tracheal tube to spontaneous ventilation, defined as a respiratory rate of more than 8 bpm and a tidal volume of at least 3 ml kg−1 for 30 s. We included 61 patients; of whom, 55 were evaluated for the primary endpoint. The median time from tracheal intubation to spontaneous ventilation was 406 s with succinylcholine and 216 s with rocuronium–sugammadex (P = 0.002). The median time from tracheal intubation to 90% recovery of the first twitch in train-of-four (T1 90%) was 518 s with succinylcholine and 168 s with rocuronium–sugammadex (P < 0.0001). Intubation conditions and time to tracheal intubation were not significantly different. RSII with rocuronium followed by reversal with sugammadex allowed earlier re-establishment of spontaneous ventilation than with succinylcholine.